AI3 Disease-Free Survival (DFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Resectable Esophageal or Gastroesophageal Junction Cancer: A Correlation Meta-Analysis

To evaluate the appropriateness of using DFS as a surrogate for OS in  trials investigating adults with resectable esophageal or gastroesophageal junction cancer (EC/GEJ) receiving therapies in the (neo)adjuvant and perioperative settings.

Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: L. Leung, M. Kurt, P. Singh, I. Kim, G. Donnellan, S. Kanters Source Type: research